| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.926 | 0.001 | 0.926 | Tyrosine 3 hydroxylase inhibitor | 0.563 0.003 DBMET00555 0.357 0.014 DBMET00586 | ||
| 0.823 | 0.001 | 0.823 | NMDA receptor subunit 3A antagonist | 0.164 0.005 DBMET00555 0.102 0.008 DBMET00586 | ||
| 0.78 | 0.001 | 0.78 | NMDA receptor subunit 3B antagonist | 0.111 0.009 DBMET00555 0.084 0.013 DBMET00586 | ||
| 0.78 | 0.004 | 0.873 | Cholesterol antagonist | 0.813 0.004 DBMET00555 0.873 0.003 DBMET00586 | DBMET00586 | |
| 0.77 | 0.006 | 0.77 | Thyroid hormone antagonist | 0.185 0.175 DBMET00555 | ||
| 0.758 | 0 | 0.758 | Thyroid hormone alpha agonist | 0.515 0.001 DBMET00555 0.446 0.001 DBMET00586 | ||
| 0.757 | 0.006 | 0.769 | Angiogenesis inhibitor | 0.769 0.005 DBMET00555 0.65 0.012 DBMET00586 | DBMET00555 | |
| 0.72 | 0.003 | 0.72 | NMDA receptor antagonist | 0.71 0.003 DBMET00555 0.077 0.069 DBMET00586 | ||
| 0.688 | 0.002 | 0.688 | Thyroid hormone alpha antagonist | 0.344 0.002 DBMET00555 0.188 0.003 DBMET00586 | ||
| 0.677 | 0.001 | 0.677 | Thyroid hormone agonist | 0.658 0.001 DBMET00555 0.088 0.003 DBMET00586 | ||
| 0.594 | 0.003 | 0.594 | Cystathionine beta-synthase inhibitor | 0.204 0.024 DBMET00555 0.54 0.003 DBMET00586 | ||
| 0.581 | 0.002 | 0.581 | Sodium/bile acid cotransporter inhibitor | 0.55 0.003 DBMET00555 0.522 0.003 DBMET00586 | ||
| 0.563 | 0.001 | 0.563 | DOPA decarboxylase inhibitor | 0.31 0.002 DBMET00555 0.262 0.003 DBMET00586 | ||
| 0.542 | 0.01 | 0.828 | Angiogenesis stimulant | 0.669 0.005 DBMET00555 0.828 0.003 DBMET00586 | DBMET00586 | |
| 0.518 | 0.029 | 0.518 | Thyroid hormone beta antagonist | |||
| 0.464 | 0.006 | 0.464 | 5 Hydroxytryptamine uptake stimulant | 0.229 0.105 DBMET00555 0.194 0.165 DBMET00586 | ||
| 0.449 | 0.001 | 0.449 | Thyroid hormone beta agonist | 0.016 0.004 DBMET00555 | ||
| 0.493 | 0.052 | 0.79 | Cyclophilin D inhibitor | 0.686 0.015 DBMET00555 0.79 0.007 DBMET00586 | DBMET00586 | |
| 0.439 | 0.003 | 0.439 | Farnesoid X receptor antagonist | 0.318 0.005 DBMET00555 0.278 0.008 DBMET00586 | ||
| 0.445 | 0.016 | 0.534 | Psychostimulant | 0.534 0.009 DBMET00586 | DBMET00586 | |
| 0.403 | 0.004 | 0.403 | Aminoacyl-tRNA synthetase inhibitor | 0.359 0.005 DBMET00555 0.345 0.005 DBMET00586 | ||
| 0.478 | 0.081 | 0.618 | Apoptosis agonist | 0.618 0.045 DBMET00586 | DBMET00586 | |
| 0.435 | 0.056 | 0.788 | Transcription factor NF kappa B inhibitor | 0.295 0.097 DBMET00555 0.788 0.014 DBMET00586 | DBMET00586 | |
| 0.36 | 0.006 | 0.36 | Glutamate receptor antagonist | 0.284 0.011 DBMET00555 0.108 0.087 DBMET00586 | ||
| 0.355 | 0.005 | 0.355 | Glutamate dehydrogenase inhibitor | 0.202 0.01 DBMET00555 0.22 0.009 DBMET00586 | ||
| 0.339 | 0.004 | 0.339 | Phenylalanine 4-hydroxylase inhibitor | 0.144 0.013 DBMET00555 0.072 0.045 DBMET00586 | ||
| 0.378 | 0.043 | 0.552 | Vasodilator, coronary | 0.552 0.01 DBMET00586 | DBMET00586 | |
| 0.367 | 0.038 | 0.469 | Interleukin 2 agonist | 0.271 0.097 DBMET00555 0.469 0.012 DBMET00586 | DBMET00586 | |
| 0.363 | 0.037 | 0.482 | DNA damaging | 0.16 0.157 DBMET00555 0.482 0.015 DBMET00586 | DBMET00586 | |
| 0.357 | 0.034 | 0.407 | Hypolipemic | 0.202 0.092 DBMET00555 0.407 0.024 DBMET00586 | DBMET00586 | |
| 0.323 | 0.002 | 0.323 | Purinergic P2X2 antagonist | 0.298 0.002 DBMET00555 0.264 0.003 DBMET00586 | ||
| 0.308 | 0.004 | 0.308 | NMDA 2A receptor antagonist | 0.217 0.004 DBMET00555 | ||
| 0.297 | 0.006 | 0.297 | Histidine decarboxylase inhibitor | |||
| 0.29 | 0.003 | 0.29 | Bile acid receptor antagonist | 0.256 0.003 DBMET00555 0.13 0.013 DBMET00586 | ||
| 0.311 | 0.035 | 0.311 | Peroxidase inhibitor | |||
| 0.327 | 0.071 | 0.601 | Immunostimulant | 0.413 0.046 DBMET00555 0.601 0.016 DBMET00586 | DBMET00586 | |
| 0.252 | 0.003 | 0.252 | Glutamate (mGluR3) antagonist | 0.039 0.022 DBMET00555 0.052 0.012 DBMET00586 | ||
| 0.268 | 0.026 | 0.569 | Protein-tyrosine phosphatase inhibitor | 0.569 0.004 DBMET00555 0.202 0.046 DBMET00586 | DBMET00555 | |
| 0.251 | 0.013 | 0.315 | Aminopeptidase B inhibitor | 0.315 0.007 DBMET00555 0.112 0.057 DBMET00586 | DBMET00555 | |
| 0.29 | 0.054 | 0.419 | Superoxide dismutase inhibitor | 0.419 0.024 DBMET00555 | DBMET00555 | |
| 0.312 | 0.081 | 0.742 | Antithrombotic | 0.528 0.025 DBMET00555 0.742 0.006 DBMET00586 | DBMET00586 | |
| 0.282 | 0.053 | 0.282 | Pyruvate kinase inhibitor | |||
| 0.294 | 0.069 | 0.299 | Hypoxia-inducible factor 1 alpha inhibitor | 0.299 0.066 DBMET00586 | DBMET00586 | |
| 0.238 | 0.018 | 0.238 | Chelator | 0.127 0.048 DBMET00586 | ||
| 0.289 | 0.074 | 0.361 | Spasmolytic | 0.361 0.049 DBMET00586 | DBMET00586 | |
| 0.253 | 0.043 | 0.253 | Growth hormone agonist | 0.125 0.113 DBMET00555 0.121 0.12 DBMET00586 | ||
| 0.223 | 0.017 | 0.223 | GABA C receptor agonist | |||
| 0.233 | 0.029 | 0.233 | Succinate dehydrogenase inhibitor | 0.17 0.081 DBMET00555 | ||
| 0.323 | 0.119 | 0.647 | Antibacterial | 0.404 0.075 DBMET00555 0.647 0.013 DBMET00586 | DBMET00586 | |
| 0.21 | 0.008 | 0.401 | NMDA 2 receptor antagonist | 0.401 0.004 DBMET00555 | DBMET00555 | |
| 0.203 | 0.005 | 0.293 | NMDA receptor agonist | 0.293 0.003 DBMET00555 | DBMET00555 | |
| 0.268 | 0.071 | 0.268 | Cardiotonic | 0.182 0.138 DBMET00586 | ||
| 0.2 | 0.004 | 0.2 | GABA aminotransferase inhibitor | 0.068 0.065 DBMET00555 0.181 0.005 DBMET00586 | ||
| 0.221 | 0.028 | 0.37 | Alpha-N-acetylglucosaminidase inhibitor | 0.37 0.01 DBMET00586 | DBMET00586 | |
| 0.216 | 0.025 | 0.469 | Protein-tyrosine phosphatase 1B inhibitor | 0.469 0.005 DBMET00555 0.181 0.034 DBMET00586 | DBMET00555 | |
| 0.188 | 0.003 | 0.188 | AMPA 4 receptor antagonist | 0.038 0.031 DBMET00555 | ||
| 0.192 | 0.007 | 0.192 | Peroxisome proliferator-activated receptor gamma agonist | 0.073 0.046 DBMET00555 0.108 0.024 DBMET00586 | ||
| 0.183 | 0.004 | 0.183 | Vitronectin receptor antagonist | 0.042 0.007 DBMET00555 | ||
| 0.186 | 0.008 | 0.186 | Glutamate decarboxylase inhibitor | 0.097 0.032 DBMET00555 | ||
| 0.185 | 0.013 | 0.374 | Selectin antagonist | 0.274 0.007 DBMET00555 0.374 0.004 DBMET00586 | DBMET00586 | |
| 0.186 | 0.016 | 0.186 | Vanilloid 1 agonist | 0.159 0.031 DBMET00555 0.183 0.017 DBMET00586 | ||
| 0.187 | 0.018 | 0.256 | Catalase inhibitor | 0.256 0.008 DBMET00555 | DBMET00555 | |
| 0.177 | 0.009 | 0.177 | Somatostatin 1 agonist | 0.131 0.019 DBMET00555 0.125 0.021 DBMET00586 | ||
| 0.252 | 0.088 | 0.252 | 5 Hydroxytryptamine release stimulant | 0.251 0.089 DBMET00586 | ||
| 0.238 | 0.075 | 0.419 | DNA synthesis inhibitor | 0.419 0.019 DBMET00586 | DBMET00586 | |
| 0.313 | 0.151 | 0.415 | 5 Hydroxytryptamine release inhibitor | 0.415 0.069 DBMET00586 | DBMET00586 | |
| 0.18 | 0.019 | 0.251 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.251 0.01 DBMET00586 | DBMET00586 | |
| 0.165 | 0.004 | 0.165 | AMPA 2 receptor antagonist | 0.055 0.01 DBMET00555 0.04 0.014 DBMET00586 | ||
| 0.238 | 0.077 | 0.303 | Vasodilator | 0.303 0.047 DBMET00586 | DBMET00586 | |
| 0.186 | 0.029 | 0.403 | Cell adhesion inhibitor | 0.175 0.033 DBMET00555 0.403 0.005 DBMET00586 | DBMET00586 | |
| 0.163 | 0.011 | 0.163 | Aminopeptidase I inhibitor | 0.084 0.038 DBMET00555 0.071 0.052 DBMET00586 | ||
| 0.155 | 0.004 | 0.155 | Kainate receptor antagonist | 0.062 0.015 DBMET00555 | ||
| 0.161 | 0.01 | 0.161 | Argininosuccinate synthase inhibitor | 0.105 0.018 DBMET00586 | ||
| 0.151 | 0.002 | 0.151 | Kainate receptor agonist | 0.066 0.005 DBMET00555 0.072 0.004 DBMET00586 | ||
| 0.179 | 0.03 | 0.179 | Cathepsin H inhibitor | 0.13 0.063 DBMET00555 | ||
| 0.154 | 0.006 | 0.154 | Glycine receptor agonist | 0.082 0.036 DBMET00555 0.134 0.009 DBMET00586 | ||
| 0.152 | 0.004 | 0.152 | Glutamate (mGluR4) antagonist | 0.046 0.025 DBMET00555 | ||
| 0.152 | 0.004 | 0.152 | Glutamate (mGluR group III) antagonist | 0.042 0.034 DBMET00555 | ||
| 0.213 | 0.071 | 0.213 | Amyloid beta aggregation inhibitor | 0.208 0.073 DBMET00586 | ||
| 0.191 | 0.051 | 0.231 | Phospholipase C inhibitor | 0.231 0.029 DBMET00555 0.165 0.079 DBMET00586 | DBMET00555 | |
| 0.183 | 0.047 | 0.183 | Neurotensin receptor agonist | |||
| 0.136 | 0.004 | 0.136 | Glutamate (mGluR7) antagonist | 0.07 0.042 DBMET00555 | ||
| 0.132 | 0.014 | 0.132 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.123 | 0.005 | 0.123 | Glutamate (mGluR6) antagonist | 0.068 0.044 DBMET00555 0.073 0.033 DBMET00586 | ||
| 0.232 | 0.115 | 0.232 | Insulysin inhibitor | |||
| 0.144 | 0.029 | 0.144 | Adenylate kinase inhibitor | 0.105 0.059 DBMET00555 0.115 0.048 DBMET00586 | ||
| 0.135 | 0.021 | 0.135 | Chymotrypsin inhibitor | 0.112 0.029 DBMET00555 | ||
| 0.129 | 0.015 | 0.129 | Vanilloid agonist | 0.113 0.022 DBMET00555 0.102 0.031 DBMET00586 | ||
| 0.146 | 0.033 | 0.224 | Photosensitizer | 0.224 0.009 DBMET00586 | DBMET00586 | |
| 0.127 | 0.016 | 0.127 | Ribonucleotide reductase inhibitor | |||
| 0.11 | 0.004 | 0.11 | Kainate receptor 2 antagonist | |||
| 0.201 | 0.097 | 0.512 | Free radical scavenger | 0.512 0.015 DBMET00586 | DBMET00586 | |
| 0.118 | 0.016 | 0.118 | Carbamoyl phosphate synthetase inhibitor | 0.079 0.029 DBMET00555 0.064 0.039 DBMET00586 | ||
| 0.142 | 0.039 | 0.312 | DNA repair enzyme inhibitor | 0.312 0.004 DBMET00586 | DBMET00586 | |
| 0.123 | 0.021 | 0.123 | Keratolytic | |||
| 0.111 | 0.013 | 0.123 | NMDA 2C receptor antagonist | 0.123 0.01 DBMET00555 | DBMET00555 | |
| 0.167 | 0.069 | 0.344 | Thrombolytic | 0.242 0.036 DBMET00555 0.344 0.018 DBMET00586 | DBMET00586 | |
| 0.121 | 0.025 | 0.21 | Phosphofructokinase-1 inhibitor | 0.21 0.01 DBMET00586 | DBMET00586 | |
| 0.125 | 0.031 | 0.125 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.134 | 0.042 | 0.175 | Nav1.4 sodium channel blocker | 0.175 0.025 DBMET00555 | DBMET00555 | |
| 0.095 | 0.004 | 0.095 | Kainate receptor 1 antagonist | 0.019 0.016 DBMET00555 | ||
| 0.106 | 0.015 | 0.106 | Ornithine carbamoyltransferase inhibitor | 0.069 0.026 DBMET00555 0.069 0.026 DBMET00586 | ||
| 0.107 | 0.017 | 0.107 | Carbonic anhydrase stimulant | 0.057 0.044 DBMET00555 | ||
| 0.182 | 0.094 | 0.182 | Insulin sensitizer | 0.166 0.112 DBMET00586 | ||
| 0.1 | 0.016 | 0.1 | NMDA receptor glycine site agonist | |||
| 0.129 | 0.046 | 0.145 | Mucolytic | 0.145 0.035 DBMET00586 | DBMET00586 | |
| 0.083 | 0.002 | 0.083 | Tryptophan hydroxylase 1 inhibitor | 0.046 0.003 DBMET00555 0.035 0.003 DBMET00586 | ||
| 0.189 | 0.108 | 0.386 | Antiamyloidogenic | 0.386 0.031 DBMET00586 | DBMET00586 | |
| 0.162 | 0.082 | 0.274 | ATPase inhibitor | 0.274 0.009 DBMET00586 | DBMET00586 | |
| 0.119 | 0.039 | 0.124 | Uric acid excretion stimulant | 0.124 0.035 DBMET00586 | DBMET00586 | |
| 0.086 | 0.006 | 0.086 | Retinoid X alpha receptor agonist | |||
| 0.108 | 0.028 | 0.108 | Opioid delta receptor antagonist | |||
| 0.111 | 0.033 | 0.111 | Ornithine decarboxylase inhibitor | 0.086 0.061 DBMET00586 | ||
| 0.079 | 0.004 | 0.079 | AMPA receptor agonist | 0.058 0.005 DBMET00555 0.048 0.01 DBMET00586 | ||
| 0.093 | 0.018 | 0.093 | 5 Hydroxytryptamine 2A agonist | |||
| 0.145 | 0.071 | 0.145 | Adenylate cyclase stimulant | 0.136 0.089 DBMET00555 | ||
| 0.081 | 0.007 | 0.081 | Fumarate hydratase inhibitor | 0.052 0.013 DBMET00586 | ||
| 0.188 | 0.116 | 0.376 | Peptidyltransferase inhibitor | 0.376 0.009 DBMET00586 | DBMET00586 | |
| 0.079 | 0.008 | 0.079 | VLA-4 antagonist | |||
| 0.082 | 0.012 | 0.082 | Epithelial sodium channel blocker | |||
| 0.078 | 0.009 | 0.078 | Leukotriene A4 hydrolase inhibitor | |||
| 0.112 | 0.044 | 0.112 | Prolactin inhibitor | |||
| 0.109 | 0.042 | 0.109 | Opioid antagonist | |||
| 0.141 | 0.074 | 0.281 | Protein kinase stimulant | 0.281 0.02 DBMET00586 | DBMET00586 | |
| 0.107 | 0.041 | 0.294 | Triose-phosphate isomerase inhibitor | 0.294 0.005 DBMET00555 0.209 0.01 DBMET00586 | DBMET00555 | |
| 0.098 | 0.032 | 0.098 | Opioid mu receptor antagonist | |||
| 0.07 | 0.005 | 0.07 | Glutamate (mGluR8) agonist | 0.035 0.034 DBMET00555 | ||
| 0.069 | 0.005 | 0.201 | NMDA 2D receptor antagonist | 0.201 0.003 DBMET00555 0.033 0.013 DBMET00586 | DBMET00555 | |
| 0.101 | 0.038 | 0.132 | ATPase (Vacuolar H+) inhibitor | 0.132 0.013 DBMET00586 | DBMET00586 | |
| 0.067 | 0.004 | 0.067 | Glutamate (mGluR8) antagonist | 0.05 0.009 DBMET00555 0.053 0.007 DBMET00586 | ||
| 0.099 | 0.037 | 0.099 | Adrenaline agonist | |||
| 0.073 | 0.011 | 0.073 | CXC chemokine 1 receptor antagonist | |||
| 0.066 | 0.005 | 0.066 | AMPA 3 receptor antagonist | |||
| 0.065 | 0.005 | 0.065 | Kainate receptor 5 antagonist | 0.029 0.01 DBMET00555 0.018 0.017 DBMET00586 | ||
| 0.063 | 0.004 | 0.063 | Tryptophan 5 hydroxylase inhibitor | 0.04 0.016 DBMET00555 | ||
| 0.071 | 0.012 | 0.071 | Growth hormone release inhibitor | 0.046 0.025 DBMET00555 0.05 0.022 DBMET00586 | ||
| 0.112 | 0.054 | 0.112 | Protease inhibitor | 0.089 0.075 DBMET00586 | ||
| 0.071 | 0.016 | 0.071 | Beta 2 adrenoreceptor antagonist | |||
| 0.141 | 0.088 | 0.476 | Anticoagulant | 0.476 0.011 DBMET00555 0.293 0.029 DBMET00586 | DBMET00555 | |
| 0.109 | 0.057 | 0.109 | Carbonic anhydrase XV inhibitor | |||
| 0.063 | 0.013 | 0.063 | Retinoid X receptor agonist | |||
| 0.079 | 0.028 | 0.079 | Beta adrenoreceptor antagonist | |||
| 0.056 | 0.006 | 0.056 | Kainate receptor 4 antagonist | 0.022 0.02 DBMET00555 | ||
| 0.076 | 0.026 | 0.076 | Prostaglandin F2 alpha antagonist | 0.057 0.051 DBMET00586 | ||
| 0.058 | 0.009 | 0.058 | Purinergic P2X3 antagonist | 0.031 0.03 DBMET00555 | ||
| 0.07 | 0.022 | 0.07 | Integrin antagonist | |||
| 0.061 | 0.014 | 0.061 | AICAR transformylase inhibitor | 0.049 0.024 DBMET00555 | ||
| 0.088 | 0.042 | 0.088 | Porphobilinogen synthase inhibitor | |||
| 0.054 | 0.007 | 0.054 | VCAM-1 antagonist | 0.038 0.032 DBMET00555 0.037 0.036 DBMET00586 | ||
| 0.054 | 0.007 | 0.054 | VCAM antagonist | 0.038 0.032 DBMET00555 0.037 0.036 DBMET00586 | ||
| 0.071 | 0.024 | 0.071 | Botulinum neurotoxin type A inhibitor | |||
| 0.115 | 0.072 | 0.115 | Adenylate cyclase inhibitor | |||
| 0.072 | 0.029 | 0.072 | Aminopeptidase microsomal inhibitor | |||
| 0.078 | 0.036 | 0.078 | Glucagon-like peptide 1 agonist | |||
| 0.151 | 0.109 | 0.411 | Hepatoprotectant | 0.196 0.067 DBMET00555 0.411 0.012 DBMET00586 | DBMET00586 | |
| 0.058 | 0.016 | 0.058 | Somatostatin 1 antagonist | 0.038 0.027 DBMET00586 | ||
| 0.07 | 0.029 | 0.07 | Cathepsin B inhibitor | |||
| 0.18 | 0.139 | 0.33 | Interleukin agonist | 0.33 0.035 DBMET00586 | DBMET00586 | |
| 0.051 | 0.012 | 0.051 | Somatostatin 5 agonist | |||
| 0.065 | 0.026 | 0.065 | Urokinase inhibitor | |||
| 0.05 | 0.011 | 0.05 | Integrin alpha4 antagonist | |||
| 0.062 | 0.024 | 0.192 | Phosphorylase inhibitor | 0.044 0.034 DBMET00555 0.192 0.005 DBMET00586 | DBMET00586 | |
| 0.068 | 0.03 | 0.068 | Alcohol oxidase inhibitor | |||
| 0.099 | 0.061 | 0.099 | Creatine kinase inhibitor | |||
| 0.044 | 0.007 | 0.044 | Glutamate (mGluR3) agonist | |||
| 0.048 | 0.012 | 0.048 | AMPA 1 receptor antagonist | |||
| 0.087 | 0.052 | 0.087 | D-Ala-D-Ala ligase inhibitor | |||
| 0.069 | 0.035 | 0.069 | Beta 3 adrenoreceptor antagonist | |||
| 0.093 | 0.06 | 0.096 | Alcohol dehydrogenase inhibitor | 0.096 0.057 DBMET00586 | DBMET00586 | |
| 0.048 | 0.017 | 0.048 | Membrane dipeptidase inhibitor | |||
| 0.099 | 0.07 | 0.327 | Expectorant | 0.327 0.007 DBMET00586 | DBMET00586 | |
| 0.034 | 0.005 | 0.034 | Kainate receptor 3 antagonist | |||
| 0.035 | 0.006 | 0.035 | Beta 1 adrenoreceptor agonist | |||
| 0.173 | 0.144 | 0.173 | Calpain inhibitor | |||
| 0.064 | 0.036 | 0.064 | Plasminogen activator inhibitor | |||
| 0.046 | 0.018 | 0.089 | Arginase inhibitor | 0.089 0.005 DBMET00586 | DBMET00586 | |
| 0.14 | 0.113 | 0.14 | Amyloid beta precursor protein antagonist | |||
| 0.099 | 0.072 | 0.099 | Ferrochelatase inhibitor | |||
| 0.048 | 0.021 | 0.048 | Beta adrenoreceptor agonist | |||
| 0.045 | 0.019 | 0.045 | Carbonic anhydrase I stimulant | |||
| 0.058 | 0.033 | 0.058 | Angiotensin-converting enzyme inhibitor | |||
| 0.059 | 0.035 | 0.059 | Kallikrein 1 inhibitor | 0.054 0.043 DBMET00586 | ||
| 0.032 | 0.009 | 0.032 | Complement factor 1r inhibitor | 0.027 0.015 DBMET00555 | ||
| 0.041 | 0.018 | 0.041 | Integrin alpha1beta1 antagonist | |||
| 0.051 | 0.031 | 0.051 | Aminopeptidase N inhibitor | |||
| 0.045 | 0.025 | 0.045 | Erythropoietin receptor agonist | |||
| 0.029 | 0.009 | 0.029 | Integrin alpha4beta7 antagonist | |||
| 0.062 | 0.043 | 0.062 | Beta 2 adrenoreceptor agonist | |||
| 0.106 | 0.088 | 0.117 | Aldehyde dehydrogenase inhibitor | 0.117 0.075 DBMET00586 | DBMET00586 | |
| 0.108 | 0.09 | 0.368 | Amylase inhibitor | 0.368 0.011 DBMET00586 | DBMET00586 | |
| 0.024 | 0.006 | 0.024 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.015 0.01 DBMET00555 | ||
| 0.029 | 0.011 | 0.07 | Glutamate (mGluR1) agonist | 0.07 0.004 DBMET00555 | DBMET00555 | |
| 0.087 | 0.069 | 0.087 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.046 | 0.029 | 0.046 | Complement C3a chemotactic receptor antagonist | |||
| 0.051 | 0.035 | 0.051 | Thromboxane A2 antagonist | |||
| 0.052 | 0.036 | 0.052 | Carbonic anhydrase II stimulant | |||
| 0.049 | 0.033 | 0.049 | Dopamine transporter inhibitor | |||
| 0.035 | 0.019 | 0.035 | Catechol O-methyltransferase inhibitor | |||
| 0.07 | 0.054 | 0.191 | Cathepsin G inhibitor | 0.191 0.017 DBMET00555 | DBMET00555 | |
| 0.077 | 0.062 | 0.129 | Glycine receptor antagonist | 0.128 0.014 DBMET00555 0.129 0.014 DBMET00586 | DBMET00586 | |
| 0.093 | 0.078 | 0.102 | Folate antagonist | 0.102 0.061 DBMET00586 | DBMET00586 | |
| 0.129 | 0.114 | 0.237 | Interferon gamma antagonist | 0.237 0.031 DBMET00586 | DBMET00586 | |
| 0.019 | 0.004 | 0.019 | Glutamate (mGluR6) agonist | |||
| 0.027 | 0.013 | 0.027 | Somatostatin 4 antagonist | 0.023 0.017 DBMET00586 | ||
| 0.065 | 0.052 | 0.065 | Sirtuin 1 inhibitor | |||
| 0.029 | 0.016 | 0.029 | Lysine carboxypeptidase inhibitor | |||
| 0.052 | 0.04 | 0.114 | Alpha-mannosidase inhibitor | 0.069 0.018 DBMET00555 0.114 0.005 DBMET00586 | DBMET00586 | |
| 0.049 | 0.038 | 0.049 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.026 | 0.016 | 0.026 | NMDA receptor glycine site antagonist | |||
| 0.068 | 0.059 | 0.068 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.073 | 0.064 | 0.182 | Cell adhesion molecule inhibitor | 0.099 0.035 DBMET00555 0.182 0.011 DBMET00586 | DBMET00586 | |
| 0.03 | 0.023 | 0.03 | Somatostatin 5 antagonist | |||
| 0.014 | 0.009 | 0.014 | Integrin beta6 antagonist | |||
| 0.019 | 0.014 | 0.019 | Integrin beta7 antagonist | |||
| 0.053 | 0.048 | 0.053 | Biliverdin reductase inhibitor | |||
| 0.104 | 0.099 | 0.104 | Toll-Like receptor 2 antagonist | |||
| 0.048 | 0.044 | 0.048 | Thromboxane antagonist | |||
| 0.122 | 0.119 | 0.122 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.051 | 0.048 | 0.051 | Dopamine uptake inhibitor | |||
| 0.019 | 0.015 | 0.019 | Somatostatin 3 antagonist | |||
| 0.024 | 0.022 | 0.024 | Urotensin II agonist | |||
| 0.057 | 0.055 | 0.057 | Neutrophil collagenase inhibitor | |||
| 0.029 | 0.027 | 0.029 | Prostacyclin antagonist | |||
| 0.039 | 0.038 | 0.039 | Neurotensin receptor antagonist | |||
| 0.016 | 0.015 | 0.016 | Aminopeptidase A inhibitor | |||
| 0.022 | 0.025 | 0.038 | Vanilloid 2 agonist | 0.038 0.004 DBMET00586 | DBMET00586 | |
| 0.038 | 0.043 | 0.117 | Mannosidase inhibitor | 0.057 0.019 DBMET00555 0.117 0.005 DBMET00586 | DBMET00586 | |
| 0.123 | 0.128 | 0.194 | Melanin inhibitor | 0.194 0.043 DBMET00586 | DBMET00586 | |
| 0.158 | 0.165 | 0.583 | Hypoglycemic | 0.583 0.009 DBMET00586 | DBMET00586 | |
| 0.083 | 0.09 | 0.12 | Interleukin 12 antagonist | 0.12 0.029 DBMET00586 | DBMET00586 | |
| 0.028 | 0.036 | 0.033 | Phosphoglycerate kinase inhibitor | 0.033 0.027 DBMET00555 | DBMET00555 | |
| 0.08 | 0.09 | 0.249 | Monophenol monooxygenase inhibitor | 0.249 0.024 DBMET00586 | DBMET00586 | |
| 0.013 | 0.024 | 0.019 | Telomerase stimulant | 0.019 0.009 DBMET00586 | DBMET00586 | |
| 0.096 | 0.109 | 0.259 | Cyclooxygenase 3 inhibitor | 0.259 0.008 DBMET00586 | DBMET00586 | |
| 0.016 | 0.03 | 0.046 | Glutamate (mGluR1a) agonist | 0.046 0.005 DBMET00555 | DBMET00555 | |
| 0.185 | 0.201 | 0.407 | Apoptosis antagonist | 0.407 0.036 DBMET00586 | DBMET00586 | |
| 0.048 | 0.067 | 0.074 | Adenine nucleotide translocase inhibitor | 0.074 0.012 DBMET00555 0.062 0.025 DBMET00586 | DBMET00555 | |
| 0.038 | 0.059 | 0.053 | Glucose-6-phosphate isomerase inhibitor | 0.053 0.025 DBMET00586 | DBMET00586 | |
| 0.027 | 0.049 | 0.624 | Cholecystokinin B agonist | 0.624 0.002 DBMET00555 | DBMET00555 | |
| 0.032 | 0.054 | 0.041 | Plasmin inhibitor | 0.041 0.038 DBMET00555 | DBMET00555 | |
| 0.084 | 0.111 | 0.21 | Alkylator | 0.21 0.024 DBMET00586 | DBMET00586 | |
| 0.046 | 0.075 | 0.06 | Sphingosine kinase inhibitor | 0.06 0.038 DBMET00555 | DBMET00555 | |
| 0.07 | 0.1 | 0.12 | NADH dehydrogenase inhibitor | 0.12 0.028 DBMET00586 | DBMET00586 | |
| 0.074 | 0.111 | 0.096 | Anabolic | 0.096 0.069 DBMET00555 | DBMET00555 | |
| 0.042 | 0.084 | 0.129 | HIV-1 integrase (3'-Processing) inhibitor | 0.129 0.017 DBMET00555 | DBMET00555 | |
| 0.039 | 0.082 | 0.117 | Heparanase inhibitor | 0.071 0.011 DBMET00555 0.117 0.003 DBMET00586 | DBMET00586 | |
| 0.126 | 0.178 | 0.153 | Neurotrophic factor enhancer | 0.153 0.134 DBMET00586 | DBMET00586 | |
| 0.067 | 0.12 | 0.146 | UDP-glucose 4-epimerase inhibitor | 0.146 0.03 DBMET00586 | DBMET00586 | |
| 0.048 | 0.102 | 0.097 | Thrombin inhibitor | 0.097 0.027 DBMET00555 | DBMET00555 | |
| 0.047 | 0.103 | 0.069 | Interferon inducer | 0.069 0.037 DBMET00586 | DBMET00586 | |
| 0.232 | 0.288 | 0.704 | Antiinflammatory | 0.704 0.03 DBMET00586 | DBMET00586 | |
| 0.054 | 0.112 | 0.087 | Interferon agonist | 0.087 0.042 DBMET00586 | DBMET00586 | |
| 0.131 | 0.191 | 0.503 | Antioxidant | 0.214 0.105 DBMET00555 0.503 0.02 DBMET00586 | DBMET00586 | |
| 0.102 | 0.164 | 0.413 | Hemostatic | 0.344 0.012 DBMET00555 0.413 0.007 DBMET00586 | DBMET00586 | |
| 0.03 | 0.1 | 0.124 | HIV-1 integrase (Strand Transfer) inhibitor | 0.124 0.016 DBMET00555 | DBMET00555 | |
| 0.011 | 0.082 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.011 DBMET00586 | DBMET00586 | |
| 0.062 | 0.134 | 0.13 | Transcription factor NF kappa B stimulant | 0.13 0.021 DBMET00586 | DBMET00586 | |
| 0.015 | 0.087 | 0.036 | 1,3-Beta-glucan synthase inhibitor | 0.036 0.005 DBMET00555 0.028 0.02 DBMET00586 | DBMET00555 | |
| 0.008 | 0.082 | 0.03 | Squalene synthetase inhibitor | 0.03 0.024 DBMET00586 | DBMET00586 | |
| 0.066 | 0.14 | 0.103 | Xanthine oxidase inhibitor | 0.103 0.057 DBMET00586 | DBMET00586 | |
| 0.064 | 0.138 | 0.11 | Thioredoxin inhibitor | 0.11 0.038 DBMET00586 | DBMET00586 | |
| 0.022 | 0.104 | 0.069 | Antibiotic Aminoglycoside-like | 0.069 0.006 DBMET00586 | DBMET00586 | |
| 0.011 | 0.106 | 0.046 | Protein 30S ribosomal subunit inhibitor | 0.046 0.009 DBMET00586 | DBMET00586 | |
| 0.143 | 0.237 | 0.171 | Nitric-oxide synthase stimulant | 0.171 0.151 DBMET00586 | DBMET00586 | |
| 0.083 | 0.187 | 0.352 | Diuretic | 0.352 0.016 DBMET00555 0.226 0.036 DBMET00586 | DBMET00555 | |
| 0.019 | 0.123 | 0.046 | Aldose reductase inhibitor | 0.046 0.043 DBMET00586 | DBMET00586 | |
| 0.068 | 0.179 | 0.225 | Lipid peroxidase inhibitor | 0.225 0.033 DBMET00586 | DBMET00586 | |
| 0.005 | 0.118 | 0.249 | Cholecystokinin B antagonist | 0.249 0.004 DBMET00555 | DBMET00555 | |
| 0.063 | 0.18 | 0.103 | Microtubule formation inhibitor | 0.103 0.085 DBMET00586 | DBMET00586 | |
| 0.04 | 0.168 | 0.06 | Lipocortins synthesis agonist | 0.06 0.035 DBMET00586 | DBMET00586 | |
| 0.03 | 0.159 | 0.1 | Carbonic anhydrase XIII inhibitor | 0.1 0.038 DBMET00555 | DBMET00555 | |
| 0.005 | 0.134 | 0.305 | Cholecystokinin A antagonist | 0.305 0.004 DBMET00555 | DBMET00555 | |
| 0.081 | 0.212 | 0.194 | Hexokinase inhibitor | 0.194 0.039 DBMET00586 | DBMET00586 | |
| 0.019 | 0.156 | 0.045 | Neuraminidase (Influenza A) inhibitor | 0.045 0.032 DBMET00586 | DBMET00586 | |
| 0.087 | 0.227 | 0.234 | DNA methylase inhibitor | 0.234 0.058 DBMET00586 | DBMET00586 | |
| 0.059 | 0.202 | 0.148 | Toll-Like receptor 4 antagonist | 0.148 0.022 DBMET00586 | DBMET00586 | |
| 0.007 | 0.153 | 0.267 | Cholecystokinin antagonist | 0.267 0.004 DBMET00555 | DBMET00555 | |
| 0.025 | 0.183 | 0.091 | Factor IXa inhibitor | 0.091 0.012 DBMET00555 0.077 0.017 DBMET00586 | DBMET00555 | |
| 0.026 | 0.197 | 0.069 | Na+ K+ transporting ATPase inhibitor | 0.069 0.061 DBMET00586 | DBMET00586 | |
| 0.005 | 0.177 | 0.536 | Cholecystokinin agonist | 0.536 0.002 DBMET00555 | DBMET00555 | |
| 0.048 | 0.223 | 0.097 | DNA polymerase I inhibitor | 0.097 0.09 DBMET00586 | DBMET00586 | |
| 0.022 | 0.213 | 0.062 | Carbonic anhydrase VA inhibitor | 0.062 0.057 DBMET00555 | DBMET00555 | |
| 0.018 | 0.218 | 0.075 | Carbonic anhydrase V inhibitor | 0.075 0.039 DBMET00555 | DBMET00555 | |
| 0.062 | 0.269 | 0.212 | Cell wall synthesis inhibitor | 0.169 0.048 DBMET00555 0.212 0.026 DBMET00586 | DBMET00586 | |
| 0.021 | 0.229 | 0.065 | Neuraminidase (influenza) inhibitor | 0.065 0.043 DBMET00586 | DBMET00586 | |
| 0.014 | 0.234 | 0.03 | Toll-Like receptor 4 agonist | 0.028 0.014 DBMET00555 0.03 0.012 DBMET00586 | DBMET00586 | |
| 0.005 | 0.225 | 0.357 | Cholecystokinin A agonist | 0.357 0.002 DBMET00555 | DBMET00555 | |
| 0.125 | 0.347 | 0.24 | Histamine release inhibitor | 0.24 0.163 DBMET00586 | DBMET00586 | |
| 0.006 | 0.234 | 0.029 | Sodium/glucose cotransporter 2 inhibitor | 0.029 0.014 DBMET00586 | DBMET00586 | |
| 0.012 | 0.245 | 0.13 | Antineoplastic antibiotic | 0.13 0.036 DBMET00586 | DBMET00586 | |
| 0.066 | 0.305 | 0.264 | Platelet antagonist | 0.264 0.067 DBMET00586 | DBMET00586 | |
| 0.103 | 0.362 | 0.209 | Antiobesity | 0.209 0.198 DBMET00586 | DBMET00586 | |
| 0.007 | 0.272 | 0.028 | Sodium/glucose cotransporter inhibitor | 0.028 0.014 DBMET00586 | DBMET00586 | |
| 0.014 | 0.284 | 0.086 | Protein 50S ribosomal subunit inhibitor | 0.086 0.017 DBMET00586 | DBMET00586 | |
| 0.054 | 0.344 | 0.279 | Nitric oxide antagonist | 0.279 0.045 DBMET00586 | DBMET00586 | |
| 0.059 | 0.351 | 0.156 | Interleukin 6 antagonist | 0.156 0.08 DBMET00586 | DBMET00586 | |
| 0.019 | 0.315 | 0.065 | Glucose-6-phosphate translocase inhibitor | 0.065 0.019 DBMET00586 | DBMET00586 | |
| 0.05 | 0.377 | 0.332 | Platelet adhesion inhibitor | 0.224 0.059 DBMET00555 0.332 0.024 DBMET00586 | DBMET00586 | |
| 0.057 | 0.383 | 0.159 | Non-steroidal antiinflammatory agent | 0.159 0.105 DBMET00586 | DBMET00586 | |
| 0.062 | 0.397 | 0.164 | Cyclic AMP phosphodiesterase inhibitor | 0.164 0.13 DBMET00586 | DBMET00586 | |
| 0.027 | 0.375 | 0.116 | AMP-activated protein kinase stimulant | 0.116 0.052 DBMET00586 | DBMET00586 | |
| 0.065 | 0.42 | 0.425 | Immunosuppressant | 0.425 0.055 DBMET00586 | DBMET00586 | |
| 0.014 | 0.371 | 0.084 | CDC25A inhibitor | 0.084 0.039 DBMET00555 | DBMET00555 | |
| 0.043 | 0.451 | 0.187 | Insulin secretagoues | 0.187 0.043 DBMET00586 | DBMET00586 | |
| 0.063 | 0.513 | 0.369 | Immunomodulator | 0.369 0.054 DBMET00586 | DBMET00586 | |
| 0.005 | 0.472 | 0.142 | NMDA 2B receptor antagonist | 0.142 0.009 DBMET00555 | DBMET00555 | |
| 0.02 | 0.579 | 0.177 | Dual specificity phosphatase inhibitor | 0.177 0.069 DBMET00555 | DBMET00555 | |
| 0.011 | 0.577 | 0.106 | Topoisomerase I inhibitor | 0.106 0.065 DBMET00586 | DBMET00586 | |
| 0.015 | 0.61 | 0.177 | Dual specificity phosphatase 3 inhibitor | 0.177 0.075 DBMET00555 | DBMET00555 | |
| 0.068 | 0.714 | 0.122 | CC chemokine 6 receptor antagonist | 0.122 0.107 DBMET00586 | DBMET00586 | |
| 0.013 | 0.672 | 0.147 | Multidrug resistance-associated protein 1 inhibitor | 0.147 0.026 DBMET00555 | DBMET00555 | |
| 0.028 | 0.796 | 0.138 | NOS3 expression enhancer | 0.138 0.085 DBMET00586 | DBMET00586 | |
| 0.008 | 0.844 | 0.218 | Tumour necrosis factor alpha release inhibitor | 0.218 0.094 DBMET00586 | DBMET00586 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |